Biodesix Inc (BDSX)
1.57
+0.01
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Biodesix Total Liabilities (Quarterly): 92.70M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 92.70M |
| December 31, 2023 | 94.52M |
| September 30, 2023 | 88.23M |
| June 30, 2023 | 84.62M |
| March 31, 2023 | 76.24M |
| December 31, 2022 | 72.30M |
| September 30, 2022 | 66.10M |
| June 30, 2022 | 67.56M |
| March 31, 2022 | 53.87M |
| Date | Value |
|---|---|
| December 31, 2021 | 56.37M |
| September 30, 2021 | 73.96M |
| June 30, 2021 | 76.03M |
| March 31, 2021 | 79.05M |
| December 31, 2020 | 79.90M |
| September 30, 2020 | 301.72M |
| June 30, 2020 | 66.37M |
| December 31, 2019 | 270.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
53.87M
Minimum
Mar 2022
301.72M
Maximum
Sep 2020
99.98M
Average
76.24M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Fonar Corp | 52.60M |
| XWELL Inc | 18.02M |
| ProPhase Labs Inc | 45.16M |
| Applied DNA Sciences Inc | 9.351M |
| Veracyte Inc | 81.42M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.20M |
| Shareholders Equity (Quarterly) | -5.502M |
| Debt to Equity Ratio | -6.462 |
| Current Ratio | 0.9119 |
| Net Debt Paydown Yield | -1.51% |